R. Mehran
Journal of the American College of Cardiology · 2000–2021
A researcher in the Science corpus: 43 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from R. Mehran's perspective
Ordered by how strongly the researchers R. Mehran trusts endorse each paper. Same corpus, a different order for every researcher.
- Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
- EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION
- ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of… (Journal of the American College of Cardiology)
- Bivalirudin for patients with acute coronary syndromes. (New England Journal of Medicine)
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients (Journal of Thrombosis and Haemostasis)
- Catastrophic outcomes of noncardiac surgery soon after coronary stenting. (Journal of the American College of Cardiology)
- Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. (Arteriosclerosis, Thrombosis and Vascular Biology)
- It's time for a change to a troponin standard. (Circulation)
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized,… (Circulation)
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (New England Journal of Medicine)
Their papers
- Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions (2007) — 5,477 citations
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) — 1,323 citations
- 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. (2021) — 956 citations
- Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. (2021) — 883 citations
- Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. (2021) — 1,036 citations
- The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. (2021) — 1,050 citations
- An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. (2020) — 767 citations
- Complete Revascularization with Multivessel PCI for Myocardial Infarction. (2019) — 726 citations
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI. (2019) — 811 citations
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation (2019) — 972 citations
- Clonal hematopoiesis and risk for atherosclerotic cardiovascular disease (2017) — 2,178 citations
- Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting (2017) — 491 citations
- Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies. (2016) — 659 citations
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016) — 1,207 citations
- Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) — 1,197 citations
- Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. (2016) — 904 citations
- 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). (2015) — 669 citations
- Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: An expert consensus document from the society for cardiovascular angiography and interventions (SCAI) (2014) — 618 citations
- Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. (2013) — 804 citations
- Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. (2012) — 1,894 citations